Study Stopped
NIH funding was terminated due to new agency priorities.
Developing a Childhood Asthma Risk Passive Digital Marker
2 other identifiers
interventional
34
1 country
1
Brief Summary
Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice. The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2023
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2025
CompletedJuly 8, 2025
July 1, 2025
1 year
April 12, 2023
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Perceived PDM acceptance
Perceived PDM acceptance will be measured using a Behavioral Intention scale (BIS).
8 to 12 months
Perceived PDM usability
Perceived Usability will be measured using a modified Simplified System Usability Scale (SUS).
8 to 12 months
Study feasibility
Percent of successful study enrollment of eligible clinicians (\>80%)
8 to 12 months
Secondary Outcomes (1)
Prognostic accuracy
3 to 12 months
Study Arms (4)
Control Clinicians - post test only
NO INTERVENTIONN=25 control pediatric clinicians, who will receive the post test only. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
PDM Intervention Clinicians - post test only
EXPERIMENTALN=25 intervention pediatric clinicians, who will receive the post test only. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
Control Clinicians - pre and post test
NO INTERVENTIONN=25 control pediatric clinicians, who will receive the pre and post test. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
PDM Intervention Clinicians - pre and post test
ACTIVE COMPARATORN=25 intervention pediatric clinicians, who will receive the pre and post test. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
Interventions
A childhood asthma Passive Digital Marker (PDM) is an ML algorithm that is able to retrieve and synthesize pre-existing "passively" collected mother/child dyad prognostic data in "digital" electronic health record (EHR) to provide an objective and quantifiable "marker" of a child's risk (probability) and associated pathophysiological phenotype to inform clinician decision-making at point-of-care.
Eligibility Criteria
You may qualify if:
- Practicing pediatricians within the IU Health Network
You may not qualify if:
- Non-practicing pediatricians within the IU Health Network
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University
Indianapolis, Indiana, 46202, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 12, 2023
First Posted
April 24, 2023
Study Start
June 1, 2024
Primary Completion
June 16, 2025
Study Completion
June 16, 2025
Last Updated
July 8, 2025
Record last verified: 2025-07